Stockreport

LEVI & KORSINSKY, LLP: PHASE III CLINICAL TRIAL DESIGN AND ENDPOINT SELECTION AT CENTER OF ULTRAGENYX PHARMACEUTICAL SECURITIES LITIGATION

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) that a class action lawsuit has b [Read more]